File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.7314/APJCP.2013.14.11.6821
- Scopus: eid_2-s2.0-84892469738
- PMID: 24377612
- WOS: WOS:000329829200109
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Soft-tissue sarcomas in the Asia-Pacific region: A systematic review
Title | Soft-tissue sarcomas in the Asia-Pacific region: A systematic review |
---|---|
Authors | |
Keywords | Incidence Survival Soft-Tissue neoplasms Sarcoma Asia-Pacific |
Issue Date | 2013 |
Citation | Asian Pacific Journal of Cancer Prevention, 2013, v. 14, n. 11, p. 6821-6832 How to Cite? |
Abstract | Background: Soft-tissue sarcomas require tailored and multidisciplinary treatment and management. However, little is known about how sarcomas are treated and managed throughout the Asia-Pacific region. Materials and Methods: MEDLINE was systematically searched using prespecified criteria. Publications (previous 10 years) that reported tumour characteristics, treatment patterns, survival outcomes, and/or safety outcomes of patients with soft-tissue sarcoma were selected. Exclusion criteria were studies of patients < 18 years of age; ≤10 patients; countries other than Australia, Hong Kong, Indonesia, Korea, Malaysia, New Zealand, Philippines, Singapore, Taiwan, or Thailand; > 20% benign tumours; sarcomas located in bones or joints; gastrointestinal stromal tumour; Kaposi's sarcoma; or not reporting relevant outcomes. Results: Of the 1,822 publications retrieved, 35 (32 studies) were included. Nearly all patients (98%, 1,992/2,024; 31 studies) were treated with surgery, and more studies used adjuvant radiotherapy than chemotherapy (24 vs 17 studies). Survival outcomes and recurrence rates varied among the studies because of the different histotypes, sites, and disease stages assessed. Only 5 studies reported safety findings. Conclusions: These findings highlight the lack of specific data available about soft-tissue sarcomas in the Asia-Pacific region. Better efforts to understand how the sarcoma is managed and treated will help improve patient outcomes in the region. |
Persistent Identifier | http://hdl.handle.net/10722/251663 |
ISSN | 2014 Impact Factor: 2.514 2023 SCImago Journal Rankings: 0.446 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ngan, Roger | - |
dc.contributor.author | Wang, Edward | - |
dc.contributor.author | Porter, David | - |
dc.contributor.author | Desai, Jayesh | - |
dc.contributor.author | Prayogo, Nugroho | - |
dc.contributor.author | Devi, Beena | - |
dc.contributor.author | Quek, Richard | - |
dc.date.accessioned | 2018-03-08T05:00:37Z | - |
dc.date.available | 2018-03-08T05:00:37Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Asian Pacific Journal of Cancer Prevention, 2013, v. 14, n. 11, p. 6821-6832 | - |
dc.identifier.issn | 1513-7368 | - |
dc.identifier.uri | http://hdl.handle.net/10722/251663 | - |
dc.description.abstract | Background: Soft-tissue sarcomas require tailored and multidisciplinary treatment and management. However, little is known about how sarcomas are treated and managed throughout the Asia-Pacific region. Materials and Methods: MEDLINE was systematically searched using prespecified criteria. Publications (previous 10 years) that reported tumour characteristics, treatment patterns, survival outcomes, and/or safety outcomes of patients with soft-tissue sarcoma were selected. Exclusion criteria were studies of patients < 18 years of age; ≤10 patients; countries other than Australia, Hong Kong, Indonesia, Korea, Malaysia, New Zealand, Philippines, Singapore, Taiwan, or Thailand; > 20% benign tumours; sarcomas located in bones or joints; gastrointestinal stromal tumour; Kaposi's sarcoma; or not reporting relevant outcomes. Results: Of the 1,822 publications retrieved, 35 (32 studies) were included. Nearly all patients (98%, 1,992/2,024; 31 studies) were treated with surgery, and more studies used adjuvant radiotherapy than chemotherapy (24 vs 17 studies). Survival outcomes and recurrence rates varied among the studies because of the different histotypes, sites, and disease stages assessed. Only 5 studies reported safety findings. Conclusions: These findings highlight the lack of specific data available about soft-tissue sarcomas in the Asia-Pacific region. Better efforts to understand how the sarcoma is managed and treated will help improve patient outcomes in the region. | - |
dc.language | eng | - |
dc.relation.ispartof | Asian Pacific Journal of Cancer Prevention | - |
dc.subject | Incidence | - |
dc.subject | Survival | - |
dc.subject | Soft-Tissue neoplasms | - |
dc.subject | Sarcoma | - |
dc.subject | Asia-Pacific | - |
dc.title | Soft-tissue sarcomas in the Asia-Pacific region: A systematic review | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.7314/APJCP.2013.14.11.6821 | - |
dc.identifier.pmid | 24377612 | - |
dc.identifier.scopus | eid_2-s2.0-84892469738 | - |
dc.identifier.volume | 14 | - |
dc.identifier.issue | 11 | - |
dc.identifier.spage | 6821 | - |
dc.identifier.epage | 6832 | - |
dc.identifier.isi | WOS:000329829200109 | - |
dc.identifier.issnl | 1513-7368 | - |